Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best July Dividend Stocks to Buy

In this article, we will take a look at the 5 Best July Dividend Stocks to Buy. For deeper discussion and analysis, read 10 Best July Dividend Stocks to Buy. 

Photo by Dan Dennis on Unsplash

5. Delta Air Lines, Inc. (NYSE:DAL)

Ex-Dividend Date: July 9

On June 26, Citi raised its price recommendation on Delta Air Lines, Inc. (NYSE:DAL) to $106 from $79. It reiterated a Buy rating on the stock as part of its Q2 earnings preview for the airline sector. The firm expects nearly every airline to beat second-quarter estimates and issue third-quarter guidance above consensus expectations. Even so, the analyst said much of that optimism already appears to be reflected in recent share price gains.

On June 25, Barclays also raised its price goal on DAL to $105 from $85. It kept an Overweight rating. The firm updated its airline price targets as part of its Q2 earnings preview. Analyst Brandon Oglenski said airlines are likely to guide third-quarter unit revenues higher, which could support a stronger margin outlook in 2027, especially if energy prices continue to trend lower. Barclays sees the strongest outlooks and the greatest potential share upside this quarter for United Airlines and Southwest. The firm also said Middle East peace has “revived interest” in US airline stocks as “robust” travel demand continues alongside flat industry capacity growth.

Delta Air Lines, Inc. (NYSE:DAL) provides scheduled air transportation for passengers and cargo throughout the United States and around the world.

4. Lennar Corporation (NYSE:LEN)

Ex-Dividend Date: July 10

On June 16, UBS lowered its price recommendation on Lennar Corporation (NYSE:LEN) to $94 from $107. It reiterated a Neutral rating on the stock. The firm updated its model following the company’s second-quarter earnings report.

The same day, JPMorgan reduced its price goal on Lennar to $77 from $80. It kept an Underweight rating. The firm said the company lowered its fiscal 2026 closings guidance after a weaker-than-expected spring selling season. Following the earnings report, JPMorgan also revised its estimates for the company.

During the Q2 2026 earnings call, Executive Chairman, CEO, and President Stuart Miller said Lennar delivered 20,519 homes during the quarter, around the midpoint of its guidance. New orders reached 21,749 homes, near the high end of the company’s projected range. He also noted that gross margin improved sequentially to 15.6%.

Miller highlighted lower sales incentives as an encouraging development. He said the sales incentive rate on home deliveries declined to 12.9% during the quarter, down from 14.1% in the first quarter and 14.5% in the fourth quarter of 2025. He added that the company was beginning to see what could be the first meaningful and potentially sustainable decline in incentive levels.

Management changes were also a focus during the call. Miller introduced Jim Parker as Lennar’s newly promoted and appointed Chief Operating Officer and David Grove as its newly promoted and appointed Executive Vice President for Homebuilding. He said the two executives would jointly oversee the company’s homebuilding operations across the country.

Lennar Corporation (NYSE:LEN) is a homebuilder and an originator of residential and commercial mortgage loans. The company also provides title insurance and closing services and develops multifamily rental properties.

3. Darden Restaurants, Inc. (NYSE:DRI)

Ex-Dividend Date: July 10

On June 26, Piper Sandler raised its price recommendation on Darden Restaurants, Inc. (NYSE:DRI) to $212 from $208. It reiterated a Neutral rating on the stock. Following Darden’s fourth-quarter results, analyst Brian Mullan said the company’s Q4 performance and initial FY27 guidance were broadly in line with expectations. He noted that the upper end of the adjusted EPS guidance came in close to the pre-print consensus. In a research note, Mullan said management pointed to the company’s ongoing scale advantages across its brands, which continue to support stronger traffic and same-store sales growth than the broader restaurant industry. The firm expects those trends to continue.

Also on June 26, BTIG raised its price goal on Darden to $235 from $225. It maintained a Buy rating on the shares. The analyst said Darden’s Q4 comparable sales exceeded expectations, reflecting a resilient consumer as traffic increased across all income groups despite elevated gas prices and broader economic pressures. The firm added that sales trends appeared stronger than earnings, as higher marketing costs, pre-opening expenses, and diesel costs weighed on profitability.

Darden Restaurants, Inc. (NYSE:DRI) owns and operates full-service dining restaurants in the United States under the trade names Olive Garden, LongHorn Steakhouse, Cheddar’s Scratch Kitchen, Chuy’s, Yard House, Ruth’s Chris Steak House (Ruth’s Chris), The Capital Grille, Seasons 52, Eddie V’s Prime Seafood (Eddie V’s), Bahama Breeze, and The Capital Burger.

2. AbbVie Inc. (NYSE:ABBV)

Ex-Dividend Date: July 15

On June 27, AbbVie Inc. (NYSE:ABBV) said the Food and Drug Administration approved Skyrizi for pediatric patients with psoriasis. The company said Skyrizi, or risankizumab-rzaa, can now be used in patients aged six years and older to treat moderate-to-severe plaque psoriasis or active psoriatic arthritis.

AbbVie also received approval for a new 55 mg pre-filled syringe for patients weighing less than 40 kg, or about 88 pounds. Patients weighing 40 kg or more can continue using the currently available 150 mg pre-filled syringe (PFS) and Pen.

According to AbbVie, about 30% of people who develop psoriasis experience symptoms before the age of 18. Skyrizi is also approved to treat adults with moderate to severe plaque psoriasis, active psoriatic arthritis, moderate to severe Crohn’s disease, and moderate to severe ulcerative colitis.

AbbVie Inc. (NYSE:ABBV) is a global, diversified, research-based biopharmaceutical company. It focuses on the research and development, manufacturing, commercialization, and sale of medicines and therapies.

1. Casey’s General Stores, Inc. (NASDAQ:CASY)

Ex-Dividend Date: July 31

On June 25, RBC Capital raised its price recommendation on Casey’s General Stores, Inc. (NASDAQ:CASY) to $850 from $794. It reiterated a Sector Perform rating on the stock. The firm said the company’s Investor Day struck a constructive tone and highlighted the strength of its senior leadership team. It also gave analysts a chance to refine their expectations for key performance metrics, especially new store development. In a research note, RBC said the assumptions supporting Casey’s projected 8% to 10% EBITDA compound annual growth rate through fiscal 2029 appear achievable, backed by the company’s strong momentum, growth drivers, and planned investments.

On the same day, Goldman Sachs raised its price goal on CASY to $795 from $695. It kept a Neutral rating on the shares. The firm said Casey’s target of 8% to 10% EBITDA growth should be achievable and could even prove conservative. In a research note, Goldman Sachs said management has executed its flywheel growth strategy effectively and used the company’s scale to balance volume and margin growth despite changing industry conditions. The firm added that this strength already seems to be reflected in Casey’s current valuation.

Casey’s General Stores, Inc. (NASDAQ:CASY) and its subsidiaries operate approximately 2,900 convenience stores across 19 states.

While we acknowledge the potential of CASY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CASY and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: Top 10 Dividend Stocks with 10%+ Yield and Billionaire Steven Cohen’s Top 11 Dividend Stock Picks

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.